Summary of Key Recommendations 1. Establish an International (EU-wide) offspring limitESHRE supports setting an international limit on the number of families created per donor to reduce uncertainty, overwhelm, and feelings of commodification among donor-conceived people and donors. Because a worldwide treaty is unrealistic, ESHRE recommends… Read More »International limits on the number of offspring per gamete donor (ESHRE stakeholder review version)

Background:The EU’s SoHO Regulation (2024/1938), which entered into force on 6 August 2024, will apply fully from 7 August 2027. This Regulation establishes a uniform legal framework across the EU/EEA for the quality, safety, and traceability of Substances of Human Origin (SoHO) — including sperm,… Read More »EU SoHO regulation – key compliance requirements & impact on fertility treatments and donor gametes (by ESHRE)

Main Recommendation:The four Nordic National Ethics Councils (Sweden, Denmark, Finland, Norway) jointly call for an international limit on the number of children that can be conceived from a single egg or sperm donor. They urge the Nordic countries to initiate EU and Council of Europe-level… Read More »The Nordic Ethics Councils are calling for international limits on how many children can be conceived from a single sperm or egg donor.

In recent years, the European Union has undertaken significant reforms to enhance the safety and quality of substances of human origin (SoHO), which encompass blood, tissues, cells, and other human-derived materials used in medical treatments. These reforms aim to modernize the regulatory framework, ensuring it… Read More »Council adopts new rules on substances of human origin

INTRO: An EuMAR project stakeholder meeting was held on the 5th of December 2023 presenting the status and receiving feedback from participants being National Competent Authorities (NCA), patient interest organisations, fertility professionals and other parties of relevance to the fertility sector and its future developments.… Read More »EuMAR project – stakeholder meeting sum-up

Together with the European Parliamentary Forum for Sexual & Reproductive Rights (EPF), ESHRE’s patient partner organisation Fertility Europe has recently launched a a White Paper on the Imperative of Equal Access to Fertility Treatments across Europe, including the following 12 key recommendations to policy makers:… Read More »Equal Access to Fertility Treatments across Europe

Research with an article published at Human Reproduction by an ESHRE working group outlines a set of add-on tests and treatments, describes the biological rationale and where available the evidence of their efficacy and safety. The ESHRE appointed working group further makes recommendations for clinical… Read More »Fertility treatment add-ons – research & recommendations

PGT-A (previously known as preimplantation genetic screening or PGS) involves checking a few cells of the embryos for potential abnormalities in the number of chromosomes. Embryos with an abnormal number of chromosomes in all or in the majority of their cells (known as aneuploid embryos)… Read More »Non-invasive preimplantation genetic testing (niPGT) – success rates?

A survey has been launched to help women in England shape reproductive health policy by sharing their experiences of a range of issues. The government launched the survey to get women’s views on issues including periods, contraception, fertility, pregnancy and the menopause, as part of… Read More »Landmark survey seeks women’s views on reproductive health in England

What is the patient journey? Firstly, let’s consider the meaning of ‘the patient journey’. It is the entire sequence of events that begins when the patient first becomes aware of your clinic. That could be browsing your clinic website, interacting with your social media or… Read More »The patient journey: why it is vital to fertility clinic success?